Yes, short term price. Because what MATTERS is the excellent science, the three separate drug platforms, and the multiple CLINICAL STAGE trials in progress, some of which are very soon to be reported.
Yes, short term price is not nearly as important as this company's intermediate term potential.
News 
Market Data 
Discover 
AI
